Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-24 @ 5:46 PM
NCT ID:
NCT06227468
Eligibility Criteria:
Inclusion Criteria:
The study will include adult subjects (age ≥ 18) that:
* possess a Greek social security number and are visiting hospitals/clinics, and/or other private laboratory institutions (incl. clinics and health care groups) as part of standard clinical practice in Greece,
* are willing and able to provide written informed consent to participate in the study according to the study protocol.
Exclusion Criteria:
* Subjects not able to provide written informed consent (e.g. ICU patients, mental illness patients, lack of legal capacity).
* Subjects who have had an allogeneic (non-self-donor):
* bone marrow transplant
* stem cell transplant
* blood transfusion less than two weeks prior to buccal swab sample collection
* liver transplant
* Subjects who participated in an interventional clinical trial in the past that according to the subject's physician opinion might have had an impact on their HLA genome.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06227468
Study Brief:
Protocol Section:
NCT06227468